34ACTIVITIES
5ORGS REPRESENTED
2BILLS
Revolving door — covered positions
Federal positions Christopher held before / during the 2-year LDA window. This is the credibility signal — who they were inside the building before they started lobbying it.
LA, Leg Counsel, LD & Counsel, Rep. Arcuri
LD & Counsel, Rep. Demings
Organizations represented
5Orgs whose LD-2 filings list Christopher as an active lobbyist, sorted by activity volume.
Topics in Filings
27Policy topics Christopher files on across all their LD-2 activities.
340B Reform×4
Drug pricing policies, implementation×4
ORPHAN Cures Act×4
HELP Copays Act×4
Pharmacy Benefit Manager transparency, including Lower Costs×4
More Transparency Act, monitoring efforts around direct-to-consumer policies×4
Drug pricing proposals×4
Pharmacy benefit manager reform×4
P.L. 119-21×4
Prescription drug advertising issues×2
Monitor issues×2
General education about policies×2
Show all 27 topics (+15 more) ▾
Impacting pharmaceutical development, approval and reimbursement×2
Drug safety and drug counterfeiting×2
Drug importation×2
340B program×2
Proposals, issues×2
Tax issues×2
Affecting the pharmaceutical industry including international tax×2
Vaccine excise tax issues×2
Medicare payment issues×2
Medicare Part D×2
Protecting Seniors Through Immunization Act×2
Prescription drug pricing issues, particularly related to MFN×2
Potential tariff actions under Section 232 of the Trade Act×2
Support for immunization access, access to migraine screening×2
Support for tick-borne disease research and womens health×2
Issue mix
LDA general-issue codes weighted by activity count.
Pharmacy6
Health Issues6
Medicare/Medicaid6
Trade (domestic/foreign)6
Taxation/Internal Revenue Code4
Communications/Broadcasting/Radio/TV2
Budget/Appropriations2
Defense2